PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 1 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,298,000 | +17.2% | 127,729 | -53.5% | 1.97% | +2.4% |
| Q1 2020 | $1,960,000 | -69.7% | 274,832 | +1.5% | 1.93% | -63.5% |
| Q4 2019 | $6,467,000 | -22.5% | 270,832 | -13.0% | 5.27% | -37.4% |
| Q3 2019 | $8,345,000 | -3.6% | 311,132 | -2.5% | 8.43% | +104.1% |
| Q2 2019 | $8,658,000 | -22.5% | 319,132 | -0.9% | 4.13% | -5.3% |
| Q1 2019 | $11,178,000 | +104.9% | 322,132 | +15.4% | 4.36% | +72.2% |
| Q4 2018 | $5,456,000 | +33.2% | 279,209 | +81.6% | 2.53% | +58.1% |
| Q3 2018 | $4,095,000 | -29.5% | 153,729 | 0.0% | 1.60% | -27.7% |
| Q2 2018 | $5,806,000 | – | 153,729 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 232,952 | $5,498,000 | 5.39% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,673,727 | $86,700,000 | 3.41% |
| Redmile Group, LLC | 1,466,537 | $34,610,000 | 3.31% |
| SECTORAL ASSET MANAGEMENT INC | 1,229,382 | $29,013,000 | 3.00% |
| HARVEY CAPITAL MANAGEMENT INC | 206,530 | $4,874,000 | 2.44% |
| Marcus Capital, LLC | 75,150 | $1,774,000 | 1.87% |
| Cormorant Asset Management, LP | 396,000 | $9,346,000 | 1.32% |
| Rail-Splitter Capital Management, LLC | 221,414 | $5,225,000 | 1.25% |
| Temasek Holdings (Private) Ltd | 6,583,568 | $155,372,000 | 1.21% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 636,526 | $15,022,000 | 0.84% |